Geriatrics News

The FDA has granted final approval for pimecrolimus cream 1%, a generic form of Elidel, according to an announcement from Glenmark Pharmaceuticals.

Outside of skin of color clinics, the satisfaction of care by black patients would improve if dermatologists underwent residency training in skin of color, cultural competency and emphatic communication skills and if there were greater dermatology workforce diversity, according to researchers in JAMA Dermatology.

Patients receiving Enbrel for inflammatory diseases other than inflammatory bowel disease have an increased risk for a diagnosis of Crohn’s disease or ulcerative colitis, according to study results.

Patients with rosacea treated with topical ivermectin 1% cream and oral doxycycline modified-release 40 mg capsules had greater visible improvement and decreased stinging and flushing compared with monotherapy, according to data from a multicenter, randomized, parallel-group comparison study conducted by James Q. Del Rosso, DO, of JDR Dermatology Research/Thomas Dermatology in Las Vegas, and colleagues.

Researchers recommend new nomenclature of “chronic pruritus of unknown origin,” or CPUO, a diagnostic workup and classification to help increase the understanding of chronic pruritus.

Among American Indian and Alaska Native populations, various barriers to dermatological care exist including reasonable access to a dermatologist, geographic distance to the clinic and insurance coverage, according to a study in JAMA Dermatology.

In a paper recently published in Journal of the American Academy of Dermatology, researchers proposed there is a three-part pathogenesis of acute inflammatory edema, a form of pseudocellulitis commonly seen in critically ill patients.

Patients with multiple sclerosis are more likely to have prevalent or incident psoriasis, but the pathway that leads to both psoriasis and MS remains unclear, according to a literature review.

As people age, the pattern, timing and extent of distant metastasis change and should be considered when treating melanoma.

Members of the Advisory Committee on Immunization Practices, or ACIP, voted 8-7 today to recommend the recently approved herpes zoster vaccine, Shingrix, over the only other FDA-approved vaccine, Zostavax.